| Breakdown | TTM | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 25.55B | 26.18B | 26.64B | 24.13B | 22.24B | 12.94B |
| Gross Profit | 13.85B | 13.49B | 14.09B | 12.80B | 10.49B | 4.02B |
| EBITDA | 1.50B | 1.84B | 2.03B | 1.48B | -57.35M | -5.04B |
| Net Income | 126.61M | 314.02M | 619.81M | 168.09M | 477.68M | -5.42B |
Balance Sheet | ||||||
| Total Assets | 20.06B | 21.58B | 23.48B | 23.30B | 24.95B | 26.60B |
| Cash, Cash Equivalents and Short-Term Investments | 3.36B | 4.57B | 5.16B | 5.41B | 6.12B | 6.72B |
| Total Debt | 8.13B | 8.24B | 9.25B | 9.82B | 10.83B | 11.13B |
| Total Liabilities | 14.12B | 15.31B | 17.24B | 17.43B | 19.03B | 21.03B |
| Stockholders Equity | 5.94B | 6.27B | 6.24B | 5.87B | 5.93B | 5.57B |
Cash Flow | ||||||
| Free Cash Flow | 0.00 | 385.33M | 885.21M | 765.47M | -471.66M | -4.87B |
| Operating Cash Flow | 0.00 | 926.34M | 1.22B | 1.10B | -247.82M | -4.49B |
| Investing Cash Flow | 0.00 | -198.47M | -591.36M | -502.14M | 132.52M | -400.64M |
| Financing Cash Flow | 0.00 | -1.31B | -915.08M | -1.32B | -486.78M | 7.49B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
69 Neutral | ¥10.17B | 5.24 | ― | 5.06% | 0.36% | 81.58% | |
64 Neutral | ¥1.71B | 12.62 | ― | 2.62% | 11.55% | 28.89% | |
61 Neutral | $18.38B | 12.79 | -2.54% | 3.03% | 1.52% | -15.83% | |
58 Neutral | ¥32.76B | 5.66 | ― | 2.48% | -4.39% | 31.40% | |
57 Neutral | ¥1.88B | 1.82 | ― | ― | 8.17% | 37.03% | |
54 Neutral | ¥3.71B | 3.91 | ― | ― | -4.35% | -132.57% | |
47 Neutral | ¥2.59B | 11.92 | ― | ― | -6.45% | 99.39% |
ESCRIT Inc. reported a sharp deterioration in results for the nine months ended 31 December 2025, with net sales down 8.7% year-on-year to ¥17.57 billion and a swing to an operating loss of ¥316 million, resulting in a net loss attributable to shareholders of ¥539 million and a basic loss per share of ¥40.35. Total assets fell to ¥19.3 billion and the equity ratio slipped to 28.1%, while the company maintained its no-dividend stance and forecast full-year sales of ¥25.04 billion and only marginal profit, underscoring continued earnings pressure and a weaker financial position for stakeholders to monitor.
The company kept its full-year outlook unchanged, projecting a steep 80.1% drop in operating profit and a net loss despite modest positive ordinary profit, reflecting management’s cautious view on recovery amid soft demand and higher costs. With no significant changes in consolidation scope or accounting policies, the results highlight structural profitability challenges, potential constraints on shareholder returns and the need for operational improvement to restore margins and balance-sheet strength.
The most recent analyst rating on (JP:2196) stock is a Sell with a Yen171.00 price target. To see the full list of analyst forecasts on ESCRIT Inc. stock, see the JP:2196 Stock Forecast page.